Related Experiment Video
Updated: Jun 12, 2026

09:03
HeLa Based Cell Free Expression Systems for Expression of Plasmodium Rhoptry Proteins
Published on: June 10, 2015
12.5K
Reconstitution of Human Cytochrome P450 Activity using a Leishmania Cell-Free Protein Expression System
Wayne A Johnston1,2, Raine E S Thomson1,3, Juan Alfaro-Palma1,2
1Centre for Agriculture and the Bioeconomy, School of Biology and Environmental Science, Queensland University of Technology, Brisbane QLD 4000, Australia.
ACS Synthetic Biology
|September 15, 2025
Summary
Researchers developed a novel cell-free protein synthesis method using Leishmania tarentolae extract for studying cytochrome P450 enzymes (P450s). This breakthrough simplifies the analysis of P450 drug metabolism and biocatalyst discovery.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Metabolism
Background:
- Cytochrome P450 enzymes (P450s) are crucial for drug metabolism and natural product biosynthesis.
- Studying eukaryotic P450s is challenging due to membrane association and reliance on partner reductases.
Purpose of the Study:
- To demonstrate cell-free synthesis and functional assay of human P450s 3A4 and 2D6.
- To overcome limitations in eukaryotic P450 expression and functional studies.
Main Methods:
- Utilized Leishmania tarentolae translational extract for cell-free synthesis.
- Coexpressed human P450s with various NADPH-cytochrome P450 reductases (CPRs).
- Assayed enzyme activity directly in unpurified cell-free reactions.
Main Results:
- Achieved successful cell-free synthesis and activity assay of P450s 3A4 and 2D6.
- Identified distinct reductase coupling preferences for P450 3A4 (human CPR) and P450 2D6 (Arabidopsis thaliana CPRs).
- Inhibition assays confirmed known P450-drug interactions.
Conclusions:
- Leishmania-based cell-free protein synthesis offers a practical solution for eukaryotic P450 expression challenges.
- Enables rapid and convenient functional studies of unmodified P450 systems.
- Provides a valuable tool for drug metabolism research and biocatalyst discovery.

